Carr Financial Group’s AbbVie ABBV Stock Holding History

Carr Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Sell	5,033 -45	-0.9%	-$9.98K	0.29%	60
2025 Q4	$1.16M	Sell	5,078 -77	-1%	-$17.5K	0.31%	57
2025 Q3	$1.19M	Sell	5,155 -97	-2%	-$19.8K	0.33%	58
2025 Q2	$975K	Buy	5,252 +40	+0.8%	+$7.43K	0.29%	66
2025 Q1	$1.09M	Buy	5,212 +156	+3%	+$30.3K	0.36%	53
2024 Q4	$899K	Sell	5,056 -218	-4%	-$40.1K	0.28%	65
2024 Q3	$1.04M	Buy	5,274 +56	+1%	+$10.5K	0.31%	61
2024 Q2	$895K	Buy	5,218 +145	+3%	+$24K	0.28%	68
2024 Q1	$924K	Sell	5,073 -325	-6%	-$56K	0.31%	63
2023 Q4	$836K	Sell	5,398 -93	-2%	-$13.6K	0.31%	62
2023 Q3	$776K	Buy	5,491 +937	+21%	+$138K	0.31%	63
2023 Q2	$614K	Buy	4,554 +469	+11%	+$68.8K	0.24%	73
2023 Q1	$651K	Sell	4,085 -2,391	-37%	-$366K	0.29%	71
2022 Q4	$1.05M	Buy	+6,476	New	+$993K	0.55%	36

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carr Financial Group's ABBV Position: Q1 2026 in Review

Carr Financial Group reduced its AbbVie (ABBV) stake by 0.89% in Q1 2026, selling an estimated $9.98K and leaving 5,033 shares worth $1.09M. The position accounts for 0.29% of the portfolio, ranked #60.

Carr Financial Group first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.19M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Carr Financial Group held 5,033 shares of AbbVie worth $1.09M as of Q1 2026.
Carr Financial Group sold 45 AbbVie shares in Q1 2026, an estimated $9.98K.
AbbVie made up 0.29% of Carr Financial Group's portfolio in Q1 2026, its #60 holding.
Carr Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Carr Financial Group's AbbVie position peaked at $1.19M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.